These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10910925)

  • 21. [Serum levels of mm23-H1 protein and their clinical implications in malignant lymphoma].
    Niitsu N
    Rinsho Ketsueki; 2001 Dec; 42(12):1155-61. PubMed ID: 11828717
    [No Abstract]   [Full Text] [Related]  

  • 22. [Expression of NM23-H(1) mRNA in acute leukemia].
    Wu S; Zhao C
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):367-9. PubMed ID: 12137595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. nm23-H1 expression in nasopharyngeal carcinoma: correlation with clinical outcome.
    Guo X; Min HQ; Zeng MS; Qian CN; Huang XM; Shao JY; Hou JH
    Int J Cancer; 1998 Dec; 79(6):596-600. PubMed ID: 9842967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage.
    Friess H; Guo XZ; Tempia-Caliera AA; Fukuda A; Martignoni ME; Zimmermann A; Korc M; Büchler MW
    J Clin Oncol; 2001 May; 19(9):2422-32. PubMed ID: 11331321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
    Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
    Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of metastasis associated proteins, CD44v6 and NM23-H1, in pediatric acute lymphoblastic leukemia.
    Magyarosy E; Sebestyén A; Timár J
    Anticancer Res; 2001; 21(1B):819-23. PubMed ID: 11299850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production.
    Okabe-Kado J; Kasukabe T; Honma Y; Kobayashi H; Maseki N; Kaneko Y
    Int J Hematol; 2009 Sep; 90(2):143-152. PubMed ID: 19655221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of the nm23-H1 protein and their clinical implication in extranodal NK/T-cell lymphoma.
    Niitsu N; Okamoto M; Honma Y; Nakamine H; Tamaru JI; Nakamura S; Yoshino T; Higashihara M; Hirano M; Okabe-Kado J;
    Leukemia; 2003 May; 17(5):987-90. PubMed ID: 12750720
    [No Abstract]   [Full Text] [Related]  

  • 29. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
    Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
    Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological and pathological relevance of extracellular NM23/NDP kinases.
    Okabe-Kado J; Kasukabe T
    J Bioenerg Biomembr; 2003 Feb; 35(1):89-93. PubMed ID: 12848346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
    Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
    Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.
    Nakopoulou LL; Constandinides CA; Tzonou A; Lazaris AC; Zervas A; Dimopoulos CA
    Histopathology; 1996 May; 28(5):429-35. PubMed ID: 8735718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate.
    Jensen SL; Wood DP; Banks ER; Veron M; Lascu I; McRoberts JW; Rangnekar VM
    World J Urol; 1996; 14 Suppl 1():S21-5. PubMed ID: 8738406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages.
    Okabe-Kado J; Kasukabe T; Honma Y
    Leuk Res; 2002 Jun; 26(6):569-76. PubMed ID: 12007505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma.
    Iizuka N; Tangoku A; Hayashi H; Yosino S; Abe T; Morioka T; Oka M
    Cancer Lett; 1999 Apr; 138(1-2):139-44. PubMed ID: 10378785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
    Iizuka N; Oka M; Noma T; Nakazawa A; Hirose K; Suzuki T
    Cancer Res; 1995 Feb; 55(3):652-7. PubMed ID: 7530600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of metastasis suppressor gene nm23-H1 in oral squamous cell carcinoma and its relation to tumor prognosis].
    Zhang T; Lai Q; Du D
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):292-4. PubMed ID: 11776896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of nm23 mRNA expression in human hepatocellular carcinoma.
    Lin LI; Lee PH; Wu CM; Lin JK
    Anticancer Res; 1998; 18(1B):541-6. PubMed ID: 9568175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.